Shares of drug developer Progen Industries (PGLA) jumped more than 160% after the company announced positive results on an experimental cancer drug.
In clinical trials, patients who had cancerous tumors removed from their livers went 76% longer before tumor recurrence when given the drug, dubbed PI-88, compared with patients not on the treatment. Shares were up $4.75 to $7.70.
I will expound on the drug PI-88 later today. Very interesting mechanism of action.
PGLA is coming back to earth today, closing at 5.20, down almost 20%. More later today.
Subscribe to:
Post Comments (Atom)
2 comments:
Much more to come from PGLA in the months to come.
Don't get caught with your pants down and no stock in the pocket, when the next announcements hit the deck.
Some good presentation material available on this site:
www.progen.com.au
thanks for that.
Post a Comment